TCL Archive Ax Falls; Recision Asked Of $17 Million For NCI This Year, $42.7 Million Cut In FY 1981 Budget April 4, 1980
TCL Archive More Cost-Effective To Use Cetuximab In Patients With Wild-Type KRAS Gene August 28, 2009
TCL Archive Hematologic Malignancies: ASCO Meeting Highlights New Approaches To Treatment July 30, 2004